Edition:
India

CytRx Corp (CYTR.OQ)

CYTR.OQ on NASDAQ Stock Exchange Capital Market

1.28USD
20 Jun 2018
Change (% chg)

$0.03 (+2.40%)
Prev Close
$1.25
Open
$1.25
Day's High
$1.29
Day's Low
$1.25
Volume
7,571
Avg. Vol
51,769
52-wk High
$5.99
52-wk Low
$1.23

Select another date:

Wed, May 16 2018

BRIEF-CytRx Announces Closing Of $7.0 Mln Registered Direct Offering

* CYTRX ANNOUNCES CLOSING OF $7.0 MILLION REGISTERED DIRECT OFFERING Source text for Eikon: Further company coverage:

BRIEF-Cytrx Announces $7.0 Million Registered Direct Offering

* CYTRX - ENTERED PURCHASE AGREEMENTS WITH CERTAIN INSTITUTIONAL INVESTORS TO SELL IN REGISTERED DIRECT OFFERING 5.6 MILLION SHARES AT PRICE OF $1.25/SHARE Source text for Eikon: Further company coverage:

BRIEF-Cytrx Reports First Quarter Loss Of $0.15 Per Share

* CASH AND CASH EQUIVALENTS OF $35.1 MILLION AS OF MARCH 31, 2018 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Cytrx Presents Statistically Significant Breakthrough Data For Its Albumin Binding Ultra High Potency Ladr Drug Candidates

* CYTRX PRESENTS STATISTICALLY SIGNIFICANT BREAKTHROUGH DATA FOR ITS ALBUMIN BINDING ULTRA HIGH POTENCY LADR DRUG CANDIDATES

BRIEF-CytRx Selects Four New LADR™ Ultra High Potency Drug Candidates For Advancement Toward Clinical Trials

* CYTRX SELECTS FOUR NEW LADR™ ULTRA HIGH POTENCY DRUG CANDIDATES FOR ADVANCEMENT TOWARD CLINICAL TRIALS

BRIEF-Cytrx Corp Announces Its Entry Into A Definitive Agreement With Destum Partners

* CYTRX CORP - ANNOUNCED ITS ENTRY INTO A DEFINITIVE AGREEMENT WITH DESTUM PARTNERS

Select another date: